Softbank's Son proposes US-Japan sovereign fund
Live Events
(You can now subscribe to our
(You can now subscribe to our Economic Times WhatsApp channel
Tokyo: SoftBank founder Masayoshi Son has proposed setting up a US-Japan sovereign wealth fund aimed at making large investments in technology and infrastructure, the Financial Times reported, citing three unidentified people close to the situation.Son has discussed the plan with US Treasury Secretary Scott Bessent , although it hasn't been formally proposed, the report said. The joint fund would likely need about $300 billion in initial capital, with significant leverage, to be effective, one person told the FT.According to the report, the fund would be jointly owned and run by the US Treasury and Japan's finance ministry, with each holding a significant stake. The fund could also be opened to limited partner investors, potentially offering retail investors in Japan and the US a chance to participate.Bessent has been looking for revenue streams for the Treasury that don't involve raising taxes, and the fund could potentially provide a solution, a person briefed on the situation told the newspaper.A Treasury spokesperson and Softbank declined to comment to the FT.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
17 minutes ago
- Indian Express
Zydus announces plan to acquire US manufacturing units of Agenus Inc
Zydus Lifesciences on Tuesday announced its plan to acquire Agenus Inc's US-based biologics CMC (Chemistry, Manufacturing, and Control) facilities, marking the Gujarat-based firm's entry into the global biologics contract development and manufacturing organisation (CDMO) business. Agenus Inc. is a clinical-stage immuno-oncology company developing immune therapies, which effectively combat cancer. Zydus, in a statement, said it is set to acquire two biologics manufacturing facilities, located in Emeryville and Berkeley, California, for an upfront consideration of USD 75 million and contingent payment of USD 50 million to be paid over three years, 'subject to achievement of certain revenue milestones'. With this acquisition, Zydus claims it will become a one-stop solution provider across the entire development spectrum of biologics, right from preclinical to toxicology studies, clinical development and now manufacturing. Zydus's CDMO business will operate as an independent entity and will house the acquired manufacturing capabilities, according to the statement. Further, Zydus will also become an exclusive contract manufacturer for Agenus and will provide manufacturing services for clinical and commercial supply of two identified Phase-3 ready immuno-oncology products, Botensilimab (BOT) and Balstilimab (BAL). In addition, Zydus will have the first right of negotiation to manufacture any of the future pipeline products developed by Agenus, the statement further read. Dr Sharvil Patel, Managing Director (MD) of Zydus Lifesciences, said, 'The acquisition will give Zydus a strategic foothold in the US for biologics manufacturing in the global hub for biotech innovation, California. It will enhance our ability to partner with innovation-centric entities, advancing new products and prioritising patient-centric solutions. This move strengthens our long-term biologics vision and positions us to better serve the evolving needs of the global biopharmaceutical industry.'
Time of India
33 minutes ago
- Time of India
'Govt needs to control its tax authorities': Raghuram Rajan's message to improve Indian business prospects
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel The former RBI governor and economist Raghuram Rajan while speaking on possible uncertainties arising due to China-US trade tensions asserted that India needs to 'control its tax authorities' to help domestic businesses."Stop having tax demands on business people which come out of the blue, which vitiate all their operations for many years. I mean, have some control. I mean, this is something that even within the government, you hear sort of worries about this kind of tax demand coming, but the government needs to control its tax authorities," said Rajan in an exclusive interview with India Today."Similarly, I think the level playing field on rules and regulations, you can't suddenly invent a regulation to benefit Indian national champions, even while, you know, hurting foreign investors who've come in. Of course, we also need to do homework for domestic firms, you know, easier rules and regulations, more transparent, as well as focus on things like land acquisition and so on," added the former RBI on India's growth, the former RBI governor said "India's growth is good, but we need need 8%-9% growth to become Viksit Bharat by 2027 because we are a relatively poor nation".The Indian economy grew by 6.5 per cent in real terms in the recently concluded financial year 2024-25, Ministry of Statistics and Programme Implementation's official data showed on to NSO's second advance estimates, the country's economy was projected to grow at 6.5 per cent in Reserve Bank of India had projected 6.5 per cent GDP growth for the fiscal year 2023-24, India's GDP grew by an impressive 9.2 per cent, continuing to be the fastest-growing major to official data, the economy grew 8.7 per cent and 7.2 percent, respectively, in 2021-22 and Ministry of Finance, in a report in March 2025, anticipated that Indian economy would achieve a growth rate of 6.5 per cent in 2024-25, despite considerable external headwinds.
&w=3840&q=100)
Business Standard
36 minutes ago
- Business Standard
MMRDA allots BKC plots to Sumitomo, Brookfield for Rs 3,840 crore
The Mumbai Metropolitan Region Development Authority (MMRDA) allotted plots in Mumbai's Bandra Kurla Complex (BKC) to entities related to Japan's Sumitomo Corporation and the US-based Brookfield for Rs 3,840.49 crore via competitive bidding. The government agency handed over allotment letters for plots C-13, C-19 and C-80 to the concerned entities in the presence of the Chief Minister of Maharashtra, Devendra Fadnavis, on Tuesday, 3 June. Goisu Realty, a group company of Sumitomo Realty & Development, has been allotted plot C-13 and C-19 for Rs 1,360.48 crore (39.61 per cent above the base price) and Rs 1,177.86 crore (40.20 per cent above the base price), respectively. The lease for plot C-80 has been awarded to Schloss Bangalore, the operator of a luxury hotels and resorts chain under the 'The Leela' brand name, for Rs 1,302.16 crore (12.34 per cent above the base price). Meanwhile, Goisu already has two office projects in BKC, with one of them scheduled for completion after 2026. The developments follow the Memoranda of Understanding (MoUs) signed by MMRDA at the World Economic Forum 2025, Davos (Switzerland), where investments of USD 12 billion were committed by Brookfield and USD 5 billion by Sumitomo for infrastructure development in the Mumbai Metropolitan Region (MMR). The total built-up area of all three plots is 86,321.80 square metres. MMRDA is expecting 15,000 high-tech jobs to be created through the developments on the plots. Recently, Sumitomo entered into an office building development project in BKC through a three-way partnership with Hines, a US-based global real estate investment manager and developer, Japan's Mitsubishi Estate Company, and Mumbai-based real estate developer Kanakia Group. The project's gross development value (GDV) is estimated to be around USD 1 billion, according to a source familiar with the matter. The consortium will develop a premium office project in Mumbai's BKC, India's costliest office hub, with an investment of Rs 3,000 crore.
